Evidence map›Paper›PMID 37881374›Full record

ArticleCureus2023

A Questionnaire Survey of Prescription Preferences and Leftover Medication Conversations: Comparisons Among Kidney Disease Patients and Healthcare Professionals.

Takeshi Nakata, Akihiro Fukuda, Kyoko Ojiro, Kazuhiro Matsuyama, Takayuki Masaki, Hiroki Itoh, Hirotaka Shibata

Abstract read
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Takeshi NakataDepartment of Endocrinology Metabolism, Rheumatology, and Nephrology, Faculty of Medicine, Oita University, Oita, JPN.
Akihiro FukudaDepartment of Endocrinology Metabolism, Rheumatology, and Nephrology, Faculty of Medicine, Oita University, Oita, JPN.
Kyoko OjiroDepartment of Internal Medicine, Matsuoka Medical Clinic, Oita, JPN.
Kazuhiro MatsuyamaDepartment of Nephrology, Matsuyama Clinic, Oita, JPN.
Takayuki MasakiDepartment of Endocrinology Metabolism, Rheumatology, and Nephrology, Faculty of Medicine, Oita University, Oita, JPN.
Hiroki ItohDepartment of Clinical Pharmacy, Oita University Hospital, Oita, JPN.
Hirotaka ShibataDepartment of Endocrinology Metabolism, Rheumatology, and Nephrology, Faculty of Medicine, Oita University, Oita, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with chronic kidney disease (CKD) and patients with kidney failure receiving hemodialysis (HD) receive various types of medications. However, little is known about the differences in medication preference and how to deal with leftover medication among CKD patients and HD patients. The purpose of this study was to investigate the differences in medication preference and ways of dealing with leftover medication between CKD patients, HD patients, physicians, and pharmacists via a questionnaire survey.

methodsThe ethics committee of Oita University, Oita, Japan, approved this survey. Outpatients undergoing treatment by a nephrologist in four facilities in Oita prefecture, Japan, were asked to answer a questionnaire on their preference for medication and how to deal with leftover medication. Respondents gave their informed written consent. The same questionnaire was administered to nephrologists and pharmacists online.

resultsIn this survey, 383 patients (260 patients with CKD and 123 patients with HD), 22 nephrologists, and 28 pharmacists responded. The response rate of valid responses was more than 90% for each of the groups. In particular, 41% of patients with CKD and 56% of patients with HD never inform their doctor about leftover medication or only inform them when there is a lot of leftover medication. On the other hand, 23% of physicians have never asked their patients about them. Ordinary logistic regression analysis indicated that there is no significant relationship between how often patients talk about leftover medication, patients' preferences, or patient states.

conclusionsDespite the age and state of the patients, it is important to discuss the perception of medication with each other and confirm the condition of the remaining medication to improve concordance and obtain the desired treatment effect.

Indexed as

adherencecompliancehemodialysisleftover medicationquestionnaire-based survey

Identifiers

PMID37881374
PMCPMC10594144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.